Critical Updates To Keep Pace With The Practical Potential Of AI & Emerging Technologies, Identify New Risks In A Volatile Geopolitical Landscape & Navigate Constantly Changing Legislation To Develop
Proactive & Innovative Risk & Compliance Strategies Across Pharma & Life Sciences
08.15 Registration & Informal Networking
OPENING REMARKS
09.00 GIC Welcome & Morning Chair’s Opening Remarks
Alex Davison, Compliance Director Europe & Global Projects, Amarin
GEOPOLITICS & INTERNATIONAL RISK
PANEL Q&A
09.10 Increase Your Proactivity & Agility In Navigating Uncertain Times By Effectively Preparing For Global Pharma Regulatory Developments In A Volatile Geopolitical Landscape
- From elections to conflict and tariffs to sanctions, discuss and debate how to monitor a rapidly changing and turbulent geopolitical landscape in order to anticipate the impact of operating a global business in a divided world
- Ensure operational continuity and ethical standards to remain steadfast in the face of potential instability and disruption
- Deep dive into the implications for your functions: not only remaining abreast of the global developments but navigating the potential consequences – or opportunities – for your operations to develop and evolve
- Proactivity not reactivity: craft agile frameworks and innovative ideas to effectively anticipate and respond to ever-changing circumstances
Lucy Sales, Senior Director – Risk & Compliance, AstraZeneca
Claire Crabtree, Senior Supplier Risk Manager, Roche
Anastasia Troyan, Senior Director Global Compliance & Ethics, Teva
Dr. Qintao Liu FRSC PhD MBA BSc, Director, Compliance Human Biological Samples, AstraZeneca
Gabor Sulyok, Global Head of Commercial and Healthcare Compliance, BioNTech
